Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Total Current Liabilities: 2009-2025

Historic Total Current Liabilities for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Sep 2025 value amounting to $546.3 million.

  • UNITED THERAPEUTICS's Total Current Liabilities fell 37.45% to $546.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $546.3 million, marking a year-over-year decrease of 37.45%. This contributed to the annual value of $738.1 million for FY2024, which is 8.24% down from last year.
  • As of Q3 2025, UNITED THERAPEUTICS's Total Current Liabilities stood at $546.3 million, which was up 3.64% from $527.1 million recorded in Q2 2025.
  • In the past 5 years, UNITED THERAPEUTICS's Total Current Liabilities registered a high of $873.4 million during Q3 2024, and its lowest value of $292.6 million during Q1 2022.
  • In the last 3 years, UNITED THERAPEUTICS's Total Current Liabilities had a median value of $738.1 million in 2024 and averaged $667.5 million.
  • As far as peak fluctuations go, UNITED THERAPEUTICS's Total Current Liabilities skyrocketed by 165.13% in 2024, and later slumped by 37.45% in 2025.
  • UNITED THERAPEUTICS's Total Current Liabilities (Quarterly) stood at $305.4 million in 2021, then grew by 12.38% to $343.2 million in 2022, then skyrocketed by 134.38% to $804.4 million in 2023, then dropped by 8.24% to $738.1 million in 2024, then tumbled by 37.45% to $546.3 million in 2025.
  • Its Total Current Liabilities stands at $546.3 million for Q3 2025, versus $527.1 million for Q2 2025 and $721.5 million for Q1 2025.